SQLite Web: event_store.db

Update row sig_152cb054045b in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","as_of":"2026-04-10T03:04:31.796915+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","company":"Whitehawk Therapeutics, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","article_chars":2092,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_037f6e6c5ed331ec","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","content_type":"text/plain","enriched_at":"2026-04-10T03:12:02.389924+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt","source_event_id":"evt_b918095e8210","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"ab0c1dc6c4a852c6","kind":"sec_filing","published_at":"20260409","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-09","2026-04-01","2026-03-02","2021-08-26","2017-03-16","2007-12-27"],"entities":[{"asset_class":"equity","name":"Whitehawk Therapeutics, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Bryan Ball","relevance":"medium","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"E-TRADE Financial Corporation","relevance":"low","symbol":"","type":"broker"},{"asset_class":"equity","name":"NASDAQ","relevance":"low","symbol":"","type":"exchange"}],"event_type":"listing","information_gaps":["What changed vs prior known state is not provided in the prompt (no prior filing state/details to compare).","The filing\u2019s specific Form 144 table fields (e.g., number of shares to be sold, aggregate sale price, remaining shares, relationship codes) are not fully unambiguous from the cleaned text excerpt.","No ticker symbol is explicitly shown in the provided text; only \u201cNASDAQ Common Stock\u201d is referenced.","The exact mapping of numeric figures (e.g., 196969, 649997.70, 47196564, 6069.80) to specific Form 144 fields is not explicitly stated in the excerpt."],"key_facts":["SEC accession number: 0001766522-26-000007.","Conformed submission type: Form 144.","Filed as of date: 2026-04-09.","Subject company: Whitehawk Therapeutics, Inc.","Former company names listed: Aadi Bioscience, Inc. (name change 2021-08-26), Aerpio Pharmaceuticals, Inc. (name change 2017-03-16), Zeta Acquisition Corp II (name change 2007-12-27).","Reporting-owner: Bryan Ball (Officer).","Security: Common Stock (also referenced as \u201cNASDAQ Common Stock\u201d).","Restricted Stock Units are referenced with dates \u201c04/01/2026\u201d and \u201c03/02/2026\u201d in the filing text.","The stated purpose includes: \u201cShares to be sold to cover withholding taxes upon vesting of restricted stock unit award.\u201d","Quantity/price figures appear in the filing text: \u201c196969\u201d and \u201c649997.70\u201d and \u201c47196564\u201d and \u201c04/09/2026\u201d (exact mapping to fields is not fully explicit in the provided text).","Signature line shows: \u201c/s/ Stephen Rodin, as Attorney-in-Fact\u201d with date \u201c04/09/2026.\u201d"],"numeric_claims":[{"label":"accession_number","value":"0001766522-26-000007"},{"label":"filed_as_of_date","value":"2026-04-09"},{"label":"restricted_stock_units_date_1","value":"04/01/2026"},{"label":"restricted_stock_units_date_2","value":"03/02/2026"},{"label":"quantity_figure_present","value":"196969"},{"label":"dollar_value_figure_present","value":"649997.70"},{"label":"another_quantity_figure_present","value":"47196564"},{"label":"price_or_other_figure_present","value":"47196564"},{"label":"signature_date","value":"04/09/2026"}],"primary_claim":"On 2026-04-09, Whitehawk Therapeutics, Inc. filed SEC Form 144 (accession 0001766522-26-000007).","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Whitehawk Therapeutics, Inc. filed a Form 144 on 2026-04-09. The filing relates to shares of its common stock to be sold to cover withholding taxes upon vesting of restricted stock units.","topics":["SEC Form 144","insider/affiliate sale","restricted stock units","withholding taxes","common stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Whitehawk Therapeutics, Inc. \u00b7 Filed 20260409","ticker":"WHWK","tickers":["WHWK"],"title":"WHWK filed 144","url":"https://www.sec.gov/Archives/edgar/data/1422142/0001766522-26-000007.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel